§ Funding Round
Series A funding round for Diagonal Therapeutics raising $130M in April 2024
Series A funding round for Diagonal Therapeutics raising $130M in April 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Atlas VentureLEAD | Organization | — |
Double Prime LLP | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | mik attisani | |
| Angel | oscar pierre | |
| Angel | Tom Blomfield | |
BVF PartnersLEAD | — | — |
| Organization | — | |
Frazier Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Viking Global Investors | — | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$255M
Top Valuation
-
Diagonal Therapeutics raised $130M in a Series A round.
The round was announced on 04/01/24.
The round was led by Atlas Venture, BVF Partners.
